Flurry of management moves on eve of JPM

More than 30 biopharma companies announced executive changes to kick off the New Year, including Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) and Immunocore Ltd. (Abingdon, U.K.), both of which brought on former AstraZeneca plc (LSE:AZN; NYSE:AZN) executives (see "AZ's Mallon to Lead Ironwood; Hecht to Helm Spinout"; "Immunocore Taps MedImmune's Jallal as CEO").

Here's BioCentury Extra's roundup in alphabetical order:...